← Insider buys
SNDX

Syndax Pharmaceuticals, Inc. · Healthcare

Chief Scientific Officer Peter Ordentlich sold $694K of Syndax Pharmaceuticals, Inc.

Sold$694,121
$23.16Price
29,972Shares
−100%Stake

What SNDX did after the filing

Prices for SNDX after this filing aren't in yet.

Traded Mon, Nov 23. Filed Wed, Nov 25, 11:38 AM ET, during the session. Not investment advice.